Dallah Healthcare Company (4004.SR) SAU
111.40
-1.4(-1.24%)
Currency In SAR
- General
- Statistics
- Historical Data
- Profile
- Financials
111.40
-1.4(-1.24%)
Currency In SAR
| Market Cap | 12.69B |
| Enterprise Value | 16.42B |
| P/E Ratio | 23.97 |
| PEG Ratio | -2.15 |
| Price/Sales Ratio | 2.65 |
| Price/Book Ratio | 2.75 |
| Enterprise/Revenue | 3.53 |
| Enterprise/EBITDA | 20.02 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.11 |
| Operating Margin | 0.12 |
| Return On Assets | 0.05 |
| Return On Equity | 0.11 |
| Revenue | 4.07B |
| Revenue/Share | 42.21 |
| Gross Profit | 1.42B |
| EBITDA | 783.5M |
| Net Income | 538M |
| Diluted EPS | 5.32 |
| Total Cash | 210.57M |
| Total Cash/Share | 2.09 |
| Total Debt | 3.93B |
| Total Debt/Equity | 0.96 |
| Current Ratio | 1.24 |
| Book Value Per Share | 40.95 |
| 52-Week Change | -7.63 |
| 52-Week High | 157.3 |
| 52-Week Low | 90 |
| Moving Average 50 Days | 122.46 |
| Moving Average 200 Days | 129.04 |
| Average Volume | 163,128 |
| Shares Outstanding | 101.1M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 1.8 |
| Payout Ratio | 0.43 |
| Last Split Factor | 6:5 |
| Last Split Date | September 14, 2020 |